Merck & Co., Inc. (NYSE:MRK) is included among the 12 Best Dogs of the Dow to Invest in. BofA Turns More Positive on Merck (MRK) Pipeline Photo by Dan Dennis on Unsplash On December 15, BofA raised its price target on Merck & Co., Inc. (NYSE:MRK) to $120 from$105 and kept a Buy rating. The analyst said the stock is starting to look more appealing as the pipeline has “rounded out,” and noted that the firm is now basing its valuation on a new FY27 EPS estimate. That optimism comes against a mixed backd ...